Table 2.
Univariate Analysis of Variables Associated With 90-Day Readmission and Completion of Completion of Parenteral Antimicrobial Therapy
| 90-Day Readmission | Completion of IV Antibiotics | |||
|---|---|---|---|---|
| Variable | OR | 95% CI | OR | 95% CI |
| Addiction medicine consult | 0.370 | .211–.648 | 4.964 | 2.734–9.011 |
| MOUD | ||||
| None | Reference | Reference | ||
| Buprenorphine maintenance | 0.426 | .202–.900 | 5.833 | 2.397–14.193 |
| Methadone maintenance | 0.528 | .255–1.092 | 1.896 | .922–3.899 |
| Methadone detoxification | 1.629 | .599–4.428 | 0.471 | .141–1.232 |
| Continuation of MOUD on DC | 0.494 | .268–.909 | 2.710 | 3.376–15.013 |
| Endocarditis | ||||
| None | Reference | Reference | ||
| Native valve | 0.864 | .495–1.507 | 2.070 | 1.818–3.626 |
| Prosthetic valve | 2.902 | .948–8.884 | 4.280 | 1.300–14.097 |
| Osteomyelitis | 0.969 | .547–1.718 | 0.367 | .204–.660 |
| Bacteremia | 0.857 | .503–1.460 | 1.136 | .922–1.263 |
| Staphylococcus aureus | 1.103 | .627–1.940 | 0.648 | .366–1.148 |
| Age ≥60 | 1.385 | .514–3.733 | 2.916 | .920–9.246 |
| Female | 1.246 | .732–2.121 | 0.692 | .406–1.180 |
| African American | 0.915 | .532–1.576 | 1.440 | .833–2.490 |
| Prior IDU infections | 2.000 | 1.118–3.578 | 1.162 | .662–2.040 |
| Hepatitis C seropositive | 1.035 | .603–1.778 | 0.711 | .412–1.226 |
Abbreviations: CI, confidence interval; DC, discharge; IDU, injection drug use; IV, intravenous; MOUD, medications for opioid use disorder; OR, odds ratio.